CTOs on the Move

Happify Health

www.happifyhealth.com

 
Happify Health designs and deploys highly engaging software that can improve mental health, physical health, and well-being across the continuum of care. And we bring all sides of healthcare together, in partnership with leading enterprises, pharma, health plans, and healthcare clients around the world.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Andrew Palan
Chief Information Officer Profile

Similar Companies

Mentholatum Company

Mentholatum Company is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Mentholatum Company is based in Orchard Park, NY. You can find more information on Mentholatum Company at www.mentholatum.com

American Health Data Services

American Health Data Services , Inc. is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New Century Health

New Century Health delivers specialty care management solutions that leverage technology and evidence-based medicine at the point-of-care, with a focus on oncology and cardiology. Our services promote the most effective treatment, reduce variability, improve clinical outcomes, and optimize cost-effectiveness.

Radicle Health

Radicle Health offers cannabis curriculum packages and modules for nurses, other healthcare professionals, and cannabis students at a range of price points.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.